SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse modelJingxin Qiao, Shengyong Yang, Ling Xu et al.|Science|2021Cited by 449
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including OmicronBaoxue Quan, Shengyong Yang, Wenpei Li et al.|Nature Microbiology|2022Cited by 101